Compare JRI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JRI | NRC |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 390.8M |
| IPO Year | N/A | 1997 |
| Metric | JRI | NRC |
|---|---|---|
| Price | $13.15 | $18.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 178.7K | 61.3K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 9.38% | 3.55% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.36 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $11.67 | $10.20 |
| 52 Week High | $14.37 | $22.79 |
| Indicator | JRI | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 62.17 |
| Support Level | $13.03 | $17.85 |
| Resistance Level | $13.38 | $18.18 |
| Average True Range (ATR) | 0.16 | 0.74 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 94.64 | 78.80 |
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.